Report
Valens Research

VREX - Embedded Expectations Analysis - 2021 10 13

Varex Imaging Corporation (VREX:USA) currently trades below corporate averages relative to UAFRS-based (Uniform) earnings, with a 14.9x Uniform P/E. At these levels, the market is pricing in bullish expectations for the firm, but management may have concerns about industrial and medical demand, gross margins, and supply chain issues.

Specifically, management may lack confidence in their ability to sustain improvements in gross margin and manufacturing productivity, maintain their cash balance, and work through supply chain issues. Furthermore, they may be concerned about volatility in R&D spending due to material costs, the sustainability of demand for their industrial and medical businesses, and the upcoming product launch on their new Z Platform.
Underlying
Varex Imaging Corporation

Varex Imaging is a designer and manufacturer of X-ray imaging components. In its Medical business segment, the company designs, manufactures, sells and services X-ray imaging components for use in a range of radiographic or fluoroscopic imaging applications including computed tomography, mammography, oncology, cardiac, surgery, dental, and computer-aided detection. In its Industrial business segment, the company designs, manufactures, sells and services X-ray imaging products for use in several markets, including security applications, such as cargo screening at ports and borders and baggage screening at airports, and nondestructive testing and inspection applications used in several other markets.

Provider
Valens Research
Valens Research

In 2009, just as the dust was settling from the last major equity and credit market crises, we launched a boutique research firm with the intention of breaking Wall Street’s biases and broken incentives:

  • GAAP and IFRS have failed to provide rules for reliable financial statement reporting
  • Stock analyst recommendations are not grounded in disciplined financial analysis
  • Credit agencies have been set up to grossly fail in their responsibilities to investors and the public markets
  • Utter lack of willingness of major research firms to employ the the most advanced forensic analysis available

We sought to provide investors and company analysts with a source of information that changed all that.
Many years later, our business model remains because little has changed on Wall Street.

  • Corporate credit ratings remain years behind the fundamental underpinnings of company performance
  • Stock analysts continue to make recommendations with deeply inherent biases
  • Research firms have failed to break down the walls between credit, equity, and macroeconomic research
  • The governing accounting bodies have created more leeway for mis-estimates and mis-classifications as financials have become unwieldy and overwhelming

The integrity of Valens Research is founded in our disciplined processes and analytics. No “star” analysts. No corporate advisory relationships. No-nonsense opinions and recommendations.

Analysts
Valens Research

Other Reports on these Companies
Other Reports from Valens Research

ResearchPool Subscriptions

Get the most out of your insights

Get in touch